Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: A meta-analysis with the FREEDOM cardiovascular outcomes trial
Matthew M.Y. Lee, Søren Lund Kristensen, Hertzel C. Gerstein, John J.V. McMurray, Naveed Sattar
Topics & Concepts
Glucagon-like peptide 1 receptorExenatideAgonistMedicineMaceInternal medicineReceptorClinical trialType 2 diabetesDiabetes mellitusDulaglutidePharmacologyEndocrinologyMyocardial infarctionConventional PCIDiabetes Treatment and ManagementHyperglycemia and glycemic control in critically ill and hospitalized patientsDiabetes, Cardiovascular Risks, and Lipoproteins